Transcription of Who Dil Lab 99.1 Rev.2 - WHO | World Health Organization
{{id}} {{{paragraph}}}
WHO/DIL/ :ENGLISHD istr.:GENERALWORLD Health ORGANIZATIONUSE OF ANTICOAGULANTS IN DIAGNOSTICLABORATORY INVESTIGATIONS2002 WHO/DIL/ 2 World Health OrganizationThis document is not a formal publication of the World Health Organization (WHO), but all rights arereserved by the Organization . The document may, however, be freely reviewed, abstracted, reproducedor translated, in part or in whole, but not for sale or for use in conjunction with commercial views expressed by named authors are solely the responsibility of those :ENGLISHD istr.:GENERALUSE OF ANTICOAGULANTS IN DIAGNOSTICLABORATORY INVESTIGATIONS&Stability of blood, plasma and serum samplesContributors:G.
WHO/DIL/LAB/99.1 Rev. 2 Page 6 1.1.4.3. Heparinates 12 to 30 IU/mL of unfractionated sodium, lithium or ammonium salt of heparin with a molecular mass of 3 to 30 kD is recommended to obtain standardized heparinized plasma (86). Calcium-titrated heparin at a concentration of 40 to 60 IU/mL blood (dry heparinisation) and 8 to 12
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}